SCHEMBL6806511

SCHEMBL6806511

CC(C(=O)NCCCCCC(=O)NN)c1cc(/N=N/c2ccccc2C(=O)O)ccc1O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.47
KMT2A Q03164 5/20 0.47
NPSR1 Q6W5P4 4/20 0.47
MAPT P10636 3/20 0.47
GAA P10253 3/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
IDE P14735 1/20 0.39
KDM4E B2RXH2 3/20 0.38
HTT P42858 3/20 0.38
MYC P01106 1/20 0.37
TDP1 Q9NUW8 2/20 0.36
PSMD14 O00487 1/20 0.36
HSP90AA1 P07900 1/20 0.36
MMP2 P08253 1/20 0.36
THRB P10828 1/20 0.36
MAPK1 P28482 1/20 0.36
HPGD P15428 2/20 0.36
LMNA P02545 1/20 0.36
TP53 P04637 1/20 0.36
NME4 O00746 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5418551 0.91 MEN1 (0.50) MEN1KMT2ANPSR1MAPTGAA
SCHEMBL5425082 0.89 MEN1 (0.50) MEN1KMT2ANPSR1MAPTGAA
SCHEMBL6808674 0.88 MEN1 (0.51) MEN1KMT2ANPSR1MAPTGAA
SCHEMBL6806131 0.84 MEN1 (0.56) MEN1KMT2ANPSR1MAPTGAA
SCHEMBL6812525 0.83 MEN1 (0.43) MEN1KMT2ANPSR1MAPTGAA
SCHEMBL5409453 0.82 MEN1 (0.44) MEN1KMT2ANPSR1MAPTGAA
SCHEMBL6806532 0.81 GAA (0.47) MEN1KMT2ANPSR1MAPTGAA
SCHEMBL6806525 0.81 GAA (0.47) MEN1KMT2ANPSR1MAPTGAA
SCHEMBL7129511 0.80 MEN1 (0.45) MEN1KMT2ANPSR1MAPTGAA
SCHEMBL8186743 0.79 MEN1 (0.42) MEN1KMT2ANPSR1MAPTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6602987-B1 4'-hydroxyazobenzene-2-carboxylic acid (HABA) compounds; useful as reagents for labeling, isolation and detection of biological molecules YEDA RESEARCH AND DEVELOPMENT CO., LTD. (IL) 2003-08-05 US claimed
US-20040067229-A1 Azobenzene derivatives as labeling agents and intermediates thereof YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2004-04-08 US disclosed
US-6602987-B1 4'-hydroxyazobenzene-2-carboxylic acid (HABA) compounds; useful as reagents for labeling, isolation and detection of biological molecules YEDA RESEARCH AND DEVELOPMENT CO., LTD. (IL) 2003-08-05 US disclosed
WO-2000027813-A1 AZOBENZENE DERIVATIVES AS LABELING AGENTS AND INTERMEDIATES THEREOF YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2000-05-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040067229-A1 Azobenzene derivatives as labeling agents and intermediates thereof CBR1, CBR3, HBB MEN1 2043/4885KMT2A 1572/4885NPSR1 593/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.